Sepsis is a life-threatening disease.
Inflammation is a major concomitant symptom of
sepsis Chrysophanol, an
anthraquinone derivative isolated from the rhizomes of rheumpalmatum, has been reported to have a protective effect against
lipopolysaccharide(LPS)-induced
inflammation. However, the underlying molecular mechanisms are not well understood. The aim of this study was to explore the effect and mechanism of
chrysophanol on
lipopolysaccharide (LPS)-induced anti-inflammatory effect of RAW264.7 cells and its involved potential mechanism. The
mRNA and
protein expression of
tumor necrosis factor (TNF)-α,
interleukin (IL)-1β and
inducible nitric oxide synthase (iNOS),
nuclear factor kappa B (NF-κB) and
PPAR-γ were measured by qRT-PCR and western blotting, the production of TNF-α, IL-1β was evaluated by ELISA. Then, the phosphorylation of NF-κB p65 was also detected by western blotting. And NF-κB p65 promoter activity was analyzed by the Dual-
Luciferase reporter assay system as well. Meanwhile,
PPAR-γ inhibitor
GW9662 was performed to knockdown
PPAR-γ expression in cells. Our data revealed that LPS induced the up-regulation of TNF-α, IL-1β, iNOS and NF-κB p65, the down-regulation of
PPAR-γ were substantially suppressed by
chrysophanol in RAW264.7 cells. Furthermore, our data also figured out that these effects of
chrysophanol were largely abrogated by
PPAR-γ inhibitor
GW9662. Taken together, our results indicated that LPS-induced
inflammation was potently compromised by
chrysophanol very likely through the
PPAR-γ-dependent inactivation of NF-κB in RAW264.7 cells.